| Ms Lauren Anne Buehler, MD, MPH | |
|
2376 Cypress Circle Ste 202, Conway, SC 29526-8994 | |
| (843) 234-9700 | |
| (843) 234-6896 |
| Full Name | Ms Lauren Anne Buehler |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 9 Years |
| Location | 2376 Cypress Circle Ste 202, Conway, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295120269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | TYPE 39 (Ohio) | Secondary |
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 85450 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Conway Medical Center | Conway, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Conway Hospital Inc | 7113839606 | 98 |
News Archive
The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.
A new seven-city study on the impact of new CPR techniques supports the widespread use of the American Heart Association's new 2005 CPR guidelines, according to the study authors in a presentation at the AHA's Scientific Sessions November 4 in Orlando.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
› Verified 2 days ago
| Entity Name | Conway Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134172000 PECOS PAC ID: 7113839606 Enrollment ID: O20031201000111 |
News Archive
The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.
A new seven-city study on the impact of new CPR techniques supports the widespread use of the American Heart Association's new 2005 CPR guidelines, according to the study authors in a presentation at the AHA's Scientific Sessions November 4 in Orlando.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lauren Anne Buehler, MD, MPH 300 Singleton Ridge Rd, Attn Patient Accounting, Conway, SC 29526-9142 Ph: (843) 234-6946 | Ms Lauren Anne Buehler, MD, MPH 2376 Cypress Circle Ste 202, Conway, SC 29526-8994 Ph: (843) 234-9700 |
News Archive
The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.
A new seven-city study on the impact of new CPR techniques supports the widespread use of the American Heart Association's new 2005 CPR guidelines, according to the study authors in a presentation at the AHA's Scientific Sessions November 4 in Orlando.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
› Verified 2 days ago
Snigdha Sharma, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Cir, Ste 100, Conway, SC 29526 Phone: 843-234-6888 Fax: 843-234-6889 | |
Nikhil Baldev Patel, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 817 Farrar Dr, Conway, SC 29526 Phone: 843-234-1660 Fax: 843-234-1661 | |
Meghan Lynne Malone, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Circle, Suite 203, Conway, SC 29526 Phone: 843-347-6038 Fax: 843-347-9808 | |
Dr. Richard H. Eisenman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Circle, Suite 203, Conway, SC 29526 Phone: 843-347-6038 Fax: 843-347-9808 | |
Dr. Hafez Hayek, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2376 Cypress Cir, Suite 100, Conway, SC 29526 Phone: 843-234-6888 Fax: 843-234-6889 | |
Dr. Martin A Duclos, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Singleton Ridge Rd, Conway, SC 29526 Phone: 843-347-1523 Fax: 843-234-6722 | |
Dr. Richard Y Hayes, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 Singleton Ridge Rd, Conway, SC 29526 Phone: 843-347-1523 Fax: 843-234-6722 |